Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0858.HK Stock Summary
Top 10 Correlated ETFs
0858.HK
In the News
0858.HK Financial details
Company Rating
Buy
Market Cap
78.87M
Income
129.27M
Revenue
72.58M
Book val./share
0.43
Cash/share
0.03
Dividend
-
Dividend %
-
Employees
169
Optionable
No
Shortable
Yes
Earnings
29 Nov 2023
P/E
0.93
Forward P/E
-
PEG
-0.48
P/S
1.42
P/B
0.08
P/C
1.1
P/FCF
-21.24
Quick Ratio
1.83
Current Ratio
3.13
Debt / Equity
0.08
LT Debt / Equity
0.08
-
-
EPS (TTM)
0.04
EPS next Y
-
EPS next Q
-
EPS this Y
-0.92%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
15.08%
Revenue last 5Y
-4.04%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-25%
SMA50
-40%
SMA100
-40%
Inst Own
-
Inst Trans
-
ROA
7%
ROE
10%
ROC
-0.01%
Gross Margin
44%
Oper. Margin
-13%
Profit Margin
192%
Payout
-
Shs Outstand
2.39B
Shs Float
945.51M
-
-
-
-
Target Price
-
52W Range
0.031-0.104
52W High
-
52W Low
-
RSI
37.77
Rel Volume
4.27
Avg Volume
787.42K
Volume
3.36M
Perf Week
-5.71%
Perf Month
-21.43%
Perf Quarter
-40%
Perf Half Y
-42.11%
-
-
-
-
Beta
0.472
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.033
Change
-2.94%
0858.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.04 | 0.03 | 0.03 | 0.03 | 0.02 | |
Net income per share | 0.03 | 0.03 | -0.05 | 0.05 | 0.04 | |
Operating cash flow per share | -0.01 | -0.01 | 0 | 0 | 0 | |
Free cash flow per share | -0.01 | -0.01 | 0 | 0 | 0 | |
Cash per share | 0.06 | 0.05 | 0.05 | 0.05 | 0.04 | |
Book value per share | 0.45 | 0.48 | 0.43 | 0.49 | 0.44 | |
Tangible book value per share | 0.44 | 0.48 | 0.43 | 0.49 | 0.44 | |
Share holders equity per share | 0.45 | 0.48 | 0.43 | 0.49 | 0.44 | |
Interest debt per share | 0.02 | 0.03 | 0.04 | 0.04 | 0.04 | |
Market cap | 253.34M | 215.1M | 372.84M | 207.93M | 196.77M | |
Enterprise value | 154.07M | 153.2M | 320M | 181.36M | 197.6M | |
P/E ratio | 3.96 | 2.58 | -3.08 | 1.59 | 1.52 | |
Price to sales ratio | 2.84 | 2.77 | 4.73 | 2.81 | 2.71 | |
POCF ratio | -16.79 | -16.23 | -437.61 | -117.74 | 166.76 | |
PFCF ratio | -15.35 | -16.04 | -237.02 | -18.25 | -36.19 | |
P/B Ratio | 0.24 | 0.19 | 0.36 | 0.18 | 0.15 | |
PTB ratio | 0.24 | 0.19 | 0.36 | 0.18 | 0.15 | |
EV to sales | 1.73 | 1.97 | 4.06 | 2.45 | 2.72 | |
Enterprise value over EBITDA | -135.87 | 43.4 | 190.93 | -28.53 | -57.81 | |
EV to operating cash flow | -10.21 | -11.56 | -375.59 | -102.69 | 167.45 | |
EV to free cash flow | -9.34 | -11.42 | -203.44 | -15.92 | -36.34 | |
Earnings yield | 0.25 | 0.39 | -0.32 | 0.63 | 0.66 | |
Free cash flow yield | -0.07 | -0.06 | 0 | -0.05 | -0.03 | |
Debt to equity | 0.05 | 0.06 | 0.07 | 0.07 | 0.08 | |
Debt to assets | 0.04 | 0.05 | 0.06 | 0.06 | 0.07 | |
Net debt to EBITDA | 87.54 | -17.54 | -31.53 | 4.18 | -0.24 | |
Current ratio | 2.62 | 3.58 | 3.65 | 3.03 | 3.13 | |
Interest coverage | -2.17 | -0.86 | -0.97 | -0.98 | -0.72 | |
Income quality | -0.24 | -0.15 | 0.01 | -0.01 | 0.01 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.3 | 0.34 | 0.3 | 0.33 | 0.35 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.09 | 0.01 | 0.85 | 5.45 | -5.61 | |
Capex to revenue | -0.02 | 0 | -0.01 | -0.13 | -0.09 | |
Capex to depreciation | -0.22 | -0.03 | -0.09 | -1.1 | -0.75 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.52 | 0.61 | 0.7 | 0.77 | 0.66 | |
ROIC | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | |
Return on tangible assets | 0.05 | 0.07 | -0.1 | 0.1 | 0.09 | |
Graham Net | 0.01 | 0 | 0 | -0.01 | -0.02 | |
Working capital | 128.9M | 150.76M | 153.19M | 130.32M | 121.65M | |
Tangible asset value | 1.05B | 1.14B | 1.03B | 1.16B | 1.28B | |
Net current asset value | 74.13M | 83.23M | 76.14M | 42.21M | 15.36M | |
Invested capital | 0.05 | 0.06 | 0.07 | 0.07 | 0.08 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 7.52M | 7.18M | 6.47M | 6.57M | 6.55M | |
Average inventory | 4.96M | 5.84M | 6.71M | 8.01M | 5.74M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 74.86 | 65.69 | 67.41 | 64.79 | 58.44 | |
Days of inventory on hand | 53.66 | 61.75 | 76.13 | 84.95 | 26.59 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 4.88 | 5.56 | 5.41 | 5.63 | 6.25 | |
Inventory turnover | 6.8 | 5.91 | 4.79 | 4.3 | 13.73 | |
ROE | 0.06 | 0.07 | -0.12 | 0.11 | 0.1 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q4
Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Net income per share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0.04 | 0.04 | 0.28 | 0.03 | 0.03 | |
Book value per share | 0.41 | 0.19 | 0.42 | 0.21 | 0.43 | |
Tangible book value per share | 0.41 | 0.42 | 0.42 | 0.43 | 0.43 | |
Share holders equity per share | 0.41 | 0.19 | 0.42 | 0.21 | 0.43 | |
Interest debt per share | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | |
Market cap | 246.3M | 288.61M | 200.89M | 236.95M | 200.96M | |
Enterprise value | 219.73M | 189.76M | 193.86M | 134.55M | 201.78M | |
P/E ratio | 2.93 | 3.15 | 2.19 | 1.42 | 1.2 | |
Price to sales ratio | 16.17 | 16.93 | 11.78 | 12.32 | 10.44 | |
POCF ratio | 270.37 | -167.46 | -116.56 | 102.42 | 86.86 | |
PFCF ratio | -63.11 | -167.46 | -116.56 | -238.15 | -201.97 | |
P/B Ratio | 0.21 | 0.52 | 0.17 | 0.37 | 0.16 | |
PTB ratio | 0.21 | 0.52 | 0.17 | 0.37 | 0.16 | |
EV to sales | 14.43 | 11.13 | 11.37 | 6.99 | 10.49 | |
Enterprise value over EBITDA | -75.64 | -84.71 | -86.54 | -1.77K | -2.66K | |
EV to operating cash flow | 241.19 | -110.1 | -112.48 | 58.16 | 87.22 | |
EV to free cash flow | -56.3 | -110.1 | -112.48 | -135.23 | -202.8 | |
Earnings yield | 0.09 | 0.08 | 0.11 | 0.18 | 0.21 | |
Free cash flow yield | -0.02 | -0.01 | -0.01 | 0 | 0 | |
Debt to equity | 0.07 | 0.16 | 0.08 | 0.16 | 0.08 | |
Debt to assets | 0.06 | 0.07 | 0.07 | 0.07 | 0.07 | |
Net debt to EBITDA | 9.15 | 44.13 | 3.14 | 1.35K | -10.83 | |
Current ratio | 3.03 | 16.19 | 16.19 | 3.13 | 3.13 | |
Interest coverage | -1.46 | -1.17 | -1.17 | -0.6 | -0.6 | |
Income quality | 0.04 | -0.08 | -0.08 | 0.06 | 0.06 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.4 | 0.36 | 0.36 | 0.35 | 0.35 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -5.28 | 0 | 0 | -1.43 | -1.43 | |
Capex to revenue | -0.32 | 0 | 0 | -0.17 | -0.17 | |
Capex to depreciation | -2.13 | 0 | 0 | -1.45 | -1.45 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.26 | 0.19 | 0.28 | 0.26 | 0.37 | |
ROIC | 0 | -0.01 | 0 | 0 | 0 | |
Return on tangible assets | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | |
Graham Net | -0.01 | -0.01 | 0.23 | -0.02 | -0.02 | |
Working capital | 130.32M | 823.33M | 823.33M | 121.65M | 121.65M | |
Tangible asset value | 1.16B | 1.2B | 1.2B | 1.28B | 1.28B | |
Net current asset value | 42.21M | 728.35M | 728.35M | 15.36M | 15.36M | |
Invested capital | 0.07 | 0.16 | 0.08 | 0.16 | 0.08 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 6.46M | 6.07M | 5.69M | 6.16M | 6.63M | |
Average inventory | 8.47M | 6.29M | 4.11M | 3.57M | 3.02M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 69.53 | 49.79 | 49.79 | 57.21 | 57.21 | |
Days of inventory on hand | 91.16 | 35.99 | 35.99 | 26.03 | 26.03 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 1.29 | 1.81 | 1.81 | 1.57 | 1.57 | |
Inventory turnover | 0.99 | 2.5 | 2.5 | 3.46 | 3.46 | |
ROE | 0.02 | 0.04 | 0.02 | 0.07 | 0.03 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
0858.HK Frequently Asked Questions
What is Extrawell Pharmaceutical Holdings Limited stock symbol ?
Extrawell Pharmaceutical Holdings Limited is a HK stock and trading under the symbol 0858.HK
What is Extrawell Pharmaceutical Holdings Limited stock quote today ?
Extrawell Pharmaceutical Holdings Limited stock price is $0.033 today.
Is Extrawell Pharmaceutical Holdings Limited stock public?
Yes, Extrawell Pharmaceutical Holdings Limited is a publicly traded company.